Bacterial Infections

Study Evaluation Tazocin Intervention

Tazocin Intervention Study

Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children

Study of Debio 1450 for Bacterial Skin Infections

Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100

To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100

A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections

Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.

Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function

A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin

A Phase 1 Safety and PK Study of IV TP-271

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

A Single Dose Study of Debio 1450 in Healthy Subjects

Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule

Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance